Opportunity ID: 348858

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DP-24-081
Funding Opportunity Title: Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 93.068 — Chronic Diseases: Research, Control, and Prevention
Cost Sharing or Matching Requirement: No
Version: Synopsis 7
Posted Date: Nov 28, 2023
Last Updated Date: Feb 21, 2024
Original Closing Date for Applications: Feb 05, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Current Closing Date for Applications: Mar 22, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Archive Date: Apr 21, 2024
Estimated Total Program Funding: $15,000,000
Award Ceiling: $950,000
Award Floor: $0

Eligibility

Eligible Applicants: City or township governments
Special district governments
County governments
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Public and State controlled institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
State governments
Independent school districts
Small businesses
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: This is a new, competitive NOFO. Prior agreements, funding, collaborations, and other arrangements with CDC are not evidence of eligibility for this NOFO.

Additional Information

Agency Name: Centers for Disease Control and Prevention – ERA
Description: Amendment III February 16, 2024Extended deadline, increased eligibility for Component B applicants, reduced description of research plan for Component B, per below. PRE-APPLICATION WEBINAR UPDATE The pre-application informational webinar will be held January 9, 2024 at 1:00 – 2:00 PM. Pre-registration is not required. Meeting URL: https://cdc.zoomgov.com/j/1618519033?pwd=UEN5WDFncGEvbHBNcXU4QmZFZHQrUT09&from=addon. Meeting ID: 161 851 9033. Passcode: 161 851 9033DESCRIPTION – The purpose of this notice of funding opportunity is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components. Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Component B: A coordinating center to harmonize data collection and analysis, and logistic and communication support to enhance the efficiency and productivity for component A. Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. This NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs. CDC intends to further research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation.
Link to Additional Information: https://sightstudies.org
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Alison Amoroso, Scientific Program Official
uxl8@cdc.gov
Email:uxl8@cdc.gov

Version History

Version Modification Description Updated Date
See Related Documents, Revised Full Announcement, for latest version. Feb 21, 2024
Modified to extend deadline of application due date to 3/22/2024, increase eligibility for Component B applicants, reduce description of research plan for Component B. Nov 28, 2023
Modified to extend deadline for application due date to 3/22/2024, increase eligibility for Component B applicants, reduce description of research plan for Component B, Nov 28, 2023
Please see NOFO for update to definitions. Nov 28, 2023
Updating the date of the Pre-Application call. All other information and application package to remain the same. Nov 28, 2023
CFDA change Nov 28, 2023
Nov 28, 2023
Jun 21, 2023

DISPLAYING: Synopsis 7

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DP-24-081
Funding Opportunity Title: Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 93.068 — Chronic Diseases: Research, Control, and Prevention
Cost Sharing or Matching Requirement: No
Version: Synopsis 7
Posted Date: Nov 28, 2023
Last Updated Date: Feb 21, 2024
Original Closing Date for Applications: Feb 05, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Current Closing Date for Applications: Mar 22, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Archive Date: Apr 21, 2024
Estimated Total Program Funding: $15,000,000
Award Ceiling: $950,000
Award Floor: $0

Eligibility

Eligible Applicants: City or township governments
Special district governments
County governments
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Public and State controlled institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
State governments
Independent school districts
Small businesses
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: This is a new, competitive NOFO. Prior agreements, funding, collaborations, and other arrangements with CDC are not evidence of eligibility for this NOFO.

Additional Information

Agency Name: Centers for Disease Control and Prevention – ERA
Description: Amendment III February 16, 2024Extended deadline, increased eligibility for Component B applicants, reduced description of research plan for Component B, per below. PRE-APPLICATION WEBINAR UPDATE The pre-application informational webinar will be held January 9, 2024 at 1:00 – 2:00 PM. Pre-registration is not required. Meeting URL: https://cdc.zoomgov.com/j/1618519033?pwd=UEN5WDFncGEvbHBNcXU4QmZFZHQrUT09&from=addon. Meeting ID: 161 851 9033. Passcode: 161 851 9033DESCRIPTION – The purpose of this notice of funding opportunity is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components. Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Component B: A coordinating center to harmonize data collection and analysis, and logistic and communication support to enhance the efficiency and productivity for component A. Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. This NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs. CDC intends to further research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation.
Link to Additional Information: https://sightstudies.org
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Alison Amoroso, Scientific Program Official
uxl8@cdc.gov
Email:uxl8@cdc.gov

DISPLAYING: Synopsis 6

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DP-24-081
Funding Opportunity Title: Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 93.068 — Chronic Diseases: Research, Control, and Prevention
Cost Sharing or Matching Requirement: No
Version: Synopsis 6
Posted Date: Nov 28, 2023
Last Updated Date: Feb 20, 2024
Original Closing Date for Applications:
Current Closing Date for Applications: Mar 22, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Archive Date: Apr 21, 2024
Estimated Total Program Funding: $15,000,000
Award Ceiling: $950,000
Award Floor: $0

Eligibility

Eligible Applicants: State governments
For profit organizations other than small businesses
Small businesses
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
Private institutions of higher education
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Public housing authorities/Indian housing authorities
County governments
Special district governments
Public and State controlled institutions of higher education
Additional Information on Eligibility: This is a new, competitive NOFO. Prior agreements, funding, collaborations, and other arrangements with CDC are not evidence of eligibility for this NOFO.

Additional Information

Agency Name: Centers for Disease Control and Prevention – ERA
Description: Amendment III February 16, 2024Extended deadline, increased eligibility for Component B applicants, reduced description of research plan for Component B, per below. PRE-APPLICATION WEBINAR UPDATE The pre-application informational webinar will be held January 9, 2024 at 1:00 – 2:00 PM. Pre-registration is not required. Meeting URL: https://cdc.zoomgov.com/j/1618519033?pwd=UEN5WDFncGEvbHBNcXU4QmZFZHQrUT09&from=addon. Meeting ID: 161 851 9033. Passcode: 161 851 9033DESCRIPTION – The purpose of this notice of funding opportunity is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components. Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Component B: A coordinating center to harmonize data collection and analysis, and logistic and communication support to enhance the efficiency and productivity for component A. Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. This NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs. CDC intends to further research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation.
Link to Additional Information: https://sightstudies.org
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Alison Amoroso, Scientific Program Official
uxl8@cdc.gov
Email:uxl8@cdc.gov

DISPLAYING: Synopsis 5

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DP-24-081
Funding Opportunity Title: Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 93.068 — Chronic Diseases: Research, Control, and Prevention
Cost Sharing or Matching Requirement: No
Version: Synopsis 5
Posted Date: Nov 28, 2023
Last Updated Date: Feb 20, 2024
Original Closing Date for Applications:
Current Closing Date for Applications: Mar 22, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Archive Date: Apr 21, 2024
Estimated Total Program Funding: $15,000,000
Award Ceiling: $950,000
Award Floor: $0

Eligibility

Eligible Applicants: State governments
For profit organizations other than small businesses
Small businesses
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
Private institutions of higher education
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Public housing authorities/Indian housing authorities
County governments
Special district governments
Public and State controlled institutions of higher education
Additional Information on Eligibility: This is a new, competitive NOFO. Prior agreements, funding, collaborations, and other arrangements with CDC are not evidence of eligibility for this NOFO.

Additional Information

Agency Name: Centers for Disease Control and Prevention – ERA
Description: Amendment III February 16, 2024Extended deadline, increased eligibility for Component B applicants, reduced description of research plan for Component B, per below. PRE-APPLICATION WEBINAR UPDATE The pre-application informational webinar will be held January 9, 2024 at 1:00 – 2:00 PM. Pre-registration is not required. Meeting URL: https://cdc.zoomgov.com/j/1618519033?pwd=UEN5WDFncGEvbHBNcXU4QmZFZHQrUT09&from=addon. Meeting ID: 161 851 9033. Passcode: 161 851 9033DESCRIPTION – The purpose of this notice of funding opportunity is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components. Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Component B: A coordinating center to harmonize data collection and analysis, and logistic and communication support to enhance the efficiency and productivity for component A. Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. This NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs. CDC intends to further research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation.
Link to Additional Information: https://sightstudies.org
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Alison Amoroso, Scientific Program Official
uxl8@cdc.gov
Email:uxl8@cdc.gov

DISPLAYING: Synopsis 4

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DP-24-081
Funding Opportunity Title: Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 93.068 — Chronic Diseases: Research, Control, and Prevention
Cost Sharing or Matching Requirement: No
Version: Synopsis 4
Posted Date: Nov 28, 2023
Last Updated Date: Jan 23, 2024
Original Closing Date for Applications:
Current Closing Date for Applications: Feb 05, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Archive Date: Apr 22, 2024
Estimated Total Program Funding: $15,000,000
Award Ceiling: $950,000
Award Floor: $0

Eligibility

Eligible Applicants: State governments
For profit organizations other than small businesses
Small businesses
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
Private institutions of higher education
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Public housing authorities/Indian housing authorities
County governments
Special district governments
Public and State controlled institutions of higher education
Additional Information on Eligibility: This is a new, competitive NOFO. Prior agreements, funding, collaborations, and other arrangements with CDC are not evidence of eligibility for this NOFO. 

Additional Information

Agency Name: Centers for Disease Control and Prevention – ERA
Description: PRE-APPLICATION WEBINAR UPDATE The pre-application informational webinar will be held January 9, 2024 at 1:00 – 2:00 PM. Pre-registration is not required. Meeting URL:    https://cdc.zoomgov.com/j/1618519033?pwd=UEN5WDFncGEvbHBNcXU4QmZFZHQrUT09&from=addon.    Meeting ID:    161 851 9033. Passcode:    161 851 9033DESCRIPTION – The purpose of this notice of funding opportunity is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components. Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Component B:  A coordinating center to harmonize data collection and analysis, and logistic and communication support to enhance the efficiency and productivity for component A. Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. This NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs. CDC intends to further research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation.
Link to Additional Information: https://sightstudies.org
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Alison Amoroso, Scientific Program Official
uxl8@cdc.gov
Email:uxl8@cdc.gov

DISPLAYING: Synopsis 3

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DP-24-081
Funding Opportunity Title: Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 93.068 — Chronic Diseases: Research, Control, and Prevention
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: Nov 28, 2023
Last Updated Date: Dec 12, 2023
Original Closing Date for Applications:
Current Closing Date for Applications: Feb 05, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Archive Date: Mar 06, 2024
Estimated Total Program Funding: $15,000,000
Award Ceiling: $950,000
Award Floor: $0

Eligibility

Eligible Applicants: State governments
For profit organizations other than small businesses
Small businesses
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
Private institutions of higher education
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Public housing authorities/Indian housing authorities
County governments
Special district governments
Public and State controlled institutions of higher education
Additional Information on Eligibility: This is a new, competitive NOFO. Prior agreements, funding, collaborations, and other arrangements with CDC are not evidence of eligibility for this NOFO. 

Additional Information

Agency Name: Centers for Disease Control and Prevention – ERA
Description: PRE-APPLICATION WEBINAR UPDATE The pre-application informational webinar will be held January 9, 2024 at 1:00 – 2:00 PM. Pre-registration is not required. Meeting URL:    https://cdc.zoomgov.com/j/1618519033?pwd=UEN5WDFncGEvbHBNcXU4QmZFZHQrUT09&from=addon.    Meeting ID:    161 851 9033. Passcode:    161 851 9033DESCRIPTION – The purpose of this notice of funding opportunity is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components. Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Component B:  A coordinating center to harmonize data collection and analysis, and logistic and communication support to enhance the efficiency and productivity for component A. Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. This NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs. CDC intends to further research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation.
Link to Additional Information: https://sightstudies.org
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Alison Amoroso, Scientific Program Official
uxl8@cdc.gov
Email:uxl8@cdc.gov

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DP-24-081
Funding Opportunity Title: Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 93.068 — Chronic Diseases: Research, Control, and Prevention
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Nov 28, 2023
Last Updated Date: Nov 28, 2023
Original Closing Date for Applications:
Current Closing Date for Applications: Feb 05, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Archive Date: Mar 06, 2024
Estimated Total Program Funding: $15,000,000
Award Ceiling: $950,000
Award Floor: $0

Eligibility

Eligible Applicants: State governments
For profit organizations other than small businesses
Small businesses
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
Private institutions of higher education
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Public housing authorities/Indian housing authorities
County governments
Special district governments
Public and State controlled institutions of higher education
Additional Information on Eligibility: This is a new, competitive NOFO. Prior agreements, funding, collaborations, and other arrangements with CDC are not evidence of eligibility for this NOFO. 

Additional Information

Agency Name: Centers for Disease Control and Prevention – ERA
Description: The purpose of this notice of funding opportunity (NOFO) is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components:Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Award recipients are expected to collaborate to establish a standard investigative protocol.Component B:  A coordinating center to provide data storage (if needed), harmonize data collection and data analysis, logistic and communication support to enhance the efficiency, productivity for component A.Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. Given the low prevalence in the general population, this NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs.In the past decade, large-scale glaucoma studies funded by CDC among high-risk groups have demonstrated success in screening and follow-up care to slow disease progression through innovative delivery programs. CDC intends to further this research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation.
Link to Additional Information: https://sightstudies.org
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Alison Amoroso
uxl8@cdc.gov
Email:uxl8@cdc.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DP-24-081
Funding Opportunity Title: Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 93.068 — Chronic Diseases: Research, Control, and Prevention
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Nov 28, 2023
Last Updated Date: Nov 28, 2023
Original Closing Date for Applications:
Current Closing Date for Applications: Feb 05, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Archive Date: Mar 06, 2024
Estimated Total Program Funding: $15,000,000
Award Ceiling: $950,000
Award Floor: $0

Eligibility

Eligible Applicants: State governments
For profit organizations other than small businesses
Small businesses
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
Private institutions of higher education
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Public housing authorities/Indian housing authorities
County governments
Special district governments
Public and State controlled institutions of higher education
Additional Information on Eligibility: This is a new, competitive NOFO. Prior agreements, funding, collaborations, and other arrangements with CDC are not evidence of eligibility for this NOFO. 

Additional Information

Agency Name: Centers for Disease Control and Prevention – ERA
Description: The purpose of this notice of funding opportunity (NOFO) is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components:Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Award recipients are expected to collaborate to establish a standard investigative protocol.Component B:  A coordinating center to provide data storage (if needed), harmonize data collection and data analysis, logistic and communication support to enhance the efficiency, productivity for component A.Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. Given the low prevalence in the general population, this NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs.In the past decade, large-scale glaucoma studies funded by CDC among high-risk groups have demonstrated success in screening and follow-up care to slow disease progression through innovative delivery programs. CDC intends to further this research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation.
Link to Additional Information: https://sightstudies.org
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Alison Amoroso
uxl8@cdc.gov
Email:uxl8@cdc.gov

DISPLAYING: Forecast 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DP-24-081
Funding Opportunity Title: Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 93.068 — Chronic Diseases: Research, Control, and Prevention
Cost Sharing or Matching Requirement: No
Version: Forecast 1
Posted Date: Jun 21, 2023
Last Updated Date: Jun 21, 2023
Original Closing Date for Applications:
Current Closing Date for Applications:
Archive Date: Feb 26, 2024
Estimated Total Program Funding: $15,000,000
Award Ceiling: $750,000
Award Floor: $0

Eligibility

Eligible Applicants: State governments
For profit organizations other than small businesses
Small businesses
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
Private institutions of higher education
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Special district governments
Public and State controlled institutions of higher education
Additional Information on Eligibility:

Additional Information

Agency Name: Centers for Disease Control and Prevention – ERA
Description: The purpose of this notice of funding opportunity (NOFO) is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components:Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Award recipients are expected to collaborate to establish a standard investigative protocol.Component B:  A coordinating center to provide data storage (if needed), harmonize data collection and data analysis, logistic and communication support to enhance the efficiency, productivity for component A.Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. Given the low prevalence in the general population, this NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs.In the past decade, large-scale glaucoma studies funded by CDC among high-risk groups have demonstrated success in screening and follow-up care to slow disease progression through innovative delivery programs. CDC intends to further this research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation.
Link to Additional Information: https://sightstudies.org
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:


Email:uxl8@cdc.gov

Folder 348858 Full Announcement-Full Announcement -> Foa_Content_of_RFA-DP-24-081 Final.pdf

Folder 348858 Revised Full Announcement-Revised Full Announcement -> Foa_Content_of_RFA-DP-24-081 Modification.pdf

Folder 348858 Other Supporting Documents-Additional Information -> Additional Information – RFA-DP-24-081.pdf

Folder 348858 Other Supporting Documents-Additional Information -> Q and A for RFA-DP24-081.pdf

Folder 348858 Other Supporting Documents-Additional Information -> RFA-DP-24-081, Final Q and A for publishing – Final.pdf

Folder 348858 Other Supporting Documents-Additional Information -> UPDATE to PRE-APPLICATION WEBINAR LINK RFA-DP-24-081.pdf

Packages

Agency Contact Information: Alison Amoroso, Scientific Program Official
uxl8@cdc.gov
Email: uxl8@cdc.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.068 RFA-DP-24-081 Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings PKG00283931 Feb 21, 2024 Mar 22, 2024 View

Package 1

Mandatory forms

348858 RR_SF424_5_0-5.0.pdf

348858 RR_Budget_3_0-3.0.pdf

348858 PHS398_ResearchPlan_5_0-5.0.pdf

348858 PHS398_CoverPageSupplement_5_0-5.0.pdf

348858 RR_OtherProjectInfo_1_4-1.4.pdf

348858 PerformanceSite_4_0-4.0.pdf

348858 RR_KeyPersonExpanded_4_0-4.0.pdf

348858 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

348858 RR_SubawardBudget30_3_0-3.0.pdf

2025-07-14T11:38:30-05:00

Share This Post, Choose Your Platform!

About the Author: